Results 261 to 270 of about 85,640 (310)

Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS Syndrome) Manifesting With Pseudolymphoma Multisystemic Organ Involvement

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Drug reaction with Eosinophilia and Systemic Symptoms is a rare significant cutaneous adverse reaction with associated mortality. Extensive pseudolymphomatous multiorgan manifestations with prolonged latency from nonsteroidal anti‐inflammatory exposure highlight the clinical spectrum and severity.
Hilary Regan   +2 more
wiley   +1 more source

Gene-expression signature predicts autoimmune toxicity in metastatic melanoma. [PDF]

open access: yesJ Immunother Cancer
Mallardo D   +22 more
europepmc   +1 more source

Menopause Exposed: Women Surveying Women [PDF]

open access: yes, 2010
Balaam, Marie-clare, Crowther, Barbara
core  

Early Onset Heart Failure due to RBM20 Variant: A Case Report Emphasizing Genetic Diagnosis and Arrhythmic Risk Stratification

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
Transthoracic echocardiography demonstrating biventricular dilatation. Parasternal long‐ and short‐axis views and apical four‐ and two‐chamber views show marked left ventricular dilatation with increased end‐diastolic volume, associated with right ventricular dilatation.
Cristian Orlando Porras Bueno   +3 more
wiley   +1 more source

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Venanprubart (LY3361237), an agonist antibody to B and T lymphocyte attenuator (BTLA), was developed as a potential treatment for autoimmune disorders, including systemic lupus erythematosus (SLE) and psoriasis. We tested venanprubart in three human Phase 1 safety studies: a single ascending dose (SAD) study in healthy participants (1/2/5/15 ...
Andrew C. Vendel   +9 more
wiley   +1 more source

Pachydermoperiostosis Associated With a Rare SLCO2A1 Mutation: A Case Report and Literature Review. [PDF]

open access: yesCureus
Mohammad M   +6 more
europepmc   +1 more source

Type 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Individuals with type 1 diabetes exhibit significantly increased prevalence of additional autoimmune diseases. Epidemiological, familial and mechanistic evidence indicates frequent polyautoimmunity and shared genetic and environmental drivers. Coexistence complicates clinical management, and autoantibody‐based detection often identifies preclinical ...
George J. Kahaly   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy